Home > Drug Search >
  • company_query: Beijing ShuangLu Pharmaceutical
  •   > 
Drug Filter
Category:
chemistry (45) biology (9)
Status:
Approved (4) NDA Filing (1) Phase Ⅲ (12) Phase Ⅱ (25) Phase Ⅰ (11) IND Filing (1)
Clinical Stage:
Pending (10) Active (30) Discontinued (10)
Bio-Type:
Gene therapy (1) Vaccine (4) Recombinant cytokines (1) Whole antibody (1)
Indication:
Meningitis (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Allergic rhinitis (AR) (1) Alzheimer's disease (AD) (1) Asthma (3) Atopic dermatitis (1) Conjunctivitis (1) Blepharitis (1) Chronic obstructive pulmonary disease (COPD) (2) Community-acquired pneumonia (CAP) (1) Constipation (1) Diabetic macular edema (1) Diarrhea (1) Duodenal ulcer (1) Dyslipidemia (2) Dyspepsia (2) Transplant rejection (1) Erectile dysfunction (ED) (1) Gastric ulcer (2) Gastroesophageal reflux disease (GERD) (1) Pancreatitis (1) Glaucoma (1) Retinal disorders (1) HBV infection (4) HCV infection (1) Septicaemia (1) Chemotherapy-induced thrombocytopenia (1) Hypercholesterolemia (1) Inflammatory bowel disease (1) Influenza virus infection (1) Insomnia (1) Irritable bowel syndrome (IBS) (2) Multiple sclerosis (MS) (1) Nausea and vomiting (1) Neuropathic pain (1) Non-alcoholic fatty liver disease (NAFLD) (1) Obesity (1) Osteoarthritis (OA) (1) Overactive bladder (OAB) (3) Peptic ulcer (2) Psoriasis (1) Respiratory tract infection (1) Rheumatoid arthritis (RA) (1) Schizophrenia (1) Sjoegren's syndrome (1) Systemic lupus erythematosus (1) Tinnitus (1) Type 2 diabetes (3) Ulcerative colitis (1) Urinary frequency (1) Urinary incontinence (1) Urinary urgency (1) Diabetic complications (1) Susceptible bacterial infections (1) Age-related macular degeneration (AMD) (1) Otorhinolaryngological infection (1) Dental infection (1) Gynecologic infection (1) Relapsed or refractory malignant lymphoma (1) Diabetes (1) Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) (1) Mucopolysaccharidosis II (Hunter syndrome) (1) Mucopolysaccharidosis I (1) Autoimmune diseases (1) Chemotherapy-radiotherapy induced mucositis (1) HDV infection (1) Plaque psoriasis (1) Thrombosis (1) Diabetic retinopathy (2) Systemic sclerosis (1) Mesothelioma (1) Interstitial cystitis (1) Corneal disorders (1) Sleep apnoea syndrome (1) Ocular inflammation (1)
Country:
Aprv. Year:
2003 (1) 2007 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top